Within this non-coding RNA, an A/C SNP at position −160 from the CDH1 transcription start site is associated with significantly increased prostate cancer risk as a result of increased recruitment of epigenetic enzymes and reduced activity of the CDH1 promoter in the presence of the A allele (12). This evidence concerns the gene CDH1 and prostate carcinoma.